Neutralizing Antibodies against West Nile Virus from Human B Cells
Demographics (2)
- AGE - Age of the donor at the time of blood draw (phv00273296.v1.p1)
- SEX - Gender of participant (phv00273297.v1.p1)
Race and Ethnicity (1)
- RACE - Race of participant (phv00273298.v1.p1)
Other (15)
- AFFECTION_STATUS - Diagnosis and stratification of WNV infection following CDC guidelines (phv00273291.v1.p1)
- ANALYTE_TYPE - Analyte Type (phv00273304.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00273303.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00273290.v1.p1)
- HISTOLOGICAL_TYPE - Cell sort (phv00273301.v1.p1)
- INFECTION_TIME - Disease status relative to time after infection (phv00273302.v1.p1)
- IS_TUMOR - Tumor status (phv00273305.v1.p1)
- SAMPLE_ID - Sample ID (phv00273299.v1.p1)
- SAMPLE_ID - Sample ID (phv00273293.v1.p1)
- SAMPLE_USE - Sample Use (phv00273294.v1.p1)
- SEQUENCING_CENTER - Name of the center which conducted sequencing (phv00273306.v1.p1)
- SUBJECT_ID - Subject ID (phv00273295.v1.p1)
- SUBJECT_ID - Subject ID (phv00273289.v1.p1)
- SUBJECT_ID - Subject ID (phv00273292.v1.p1)
- VISIT - Visit number (phv00273300.v1.p1)